InfuSystem Holdings, Inc. (INFU) Stock Price

INFUStock

$13.40+44.24%52W

Market Cap$270.43M

P/E40.27x

PEG Ratio1.73

Div yield—

Beta1.42

INFU Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)24.23%

Price vs S&P 500 (4W)6.01%

PEG Ratio1.73

VGM Score65.36

P/E Ratio (Annual)40.27x

P/CF (Annual)10.93x

Book Value / Share (Quarterly)$2.97

P/TBV (Annual)3.62x

Revenue Growth (3Y)9.28%

Cash Flow / Share (Quarterly)$0.63

Price vs S&P 500 (YTD)37.46%

Gross Margin (TTM)57.45%

Net Profit Margin (TTM)5.96%

EPS (TTM)$0.41

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$0.41

Revenue Growth (5Y)8.05%

EPS (Annual)$0.31

ROI (Annual)8.61%

Gross Margin (Annual)55.98%

Net Profit Margin (5Y Avg)1.69%

Cash / Share (Quarterly)$0.05

P/E Basic Excl Extra (TTM)31.24x

Revenue Growth QoQ (YoY)2.59%

EPS Growth (5Y)-17.01%

P/E Normalized (Annual)40.27x

ROA (Last FY)6.59%

Revenue Growth TTM (YoY)2.47%

EBITD / Share (TTM)$0.73

ROE (5Y Avg)4.06%

Operating Margin (TTM)9.26%

Cash Flow / Share (Annual)$0.78

P/B Ratio4.51x

P/B Ratio (Quarterly)3.29x

Net Income / Employee (Annual)$14,400

EV / Revenue (TTM)2.00x

Net Interest Coverage (TTM)9.18x

ROA (TTM)8.63%

EPS Growth QoQ (YoY)25.12%

EV / EBITDA (TTM)18.75x

EPS Incl Extra (Annual)$0.31

Current Ratio (Annual)1.80x

Quick Ratio (Quarterly)2.14x

3-Month Avg Trading Volume0.17M

52-Week Price Return44.24%

EV / Free Cash Flow (Annual)18.21x

P/E Incl Extra (TTM)31.24x

Revenue / Employee (TTM)$310,900

Tangible BV / Share (Quarterly)$2.64

P/S Ratio (Annual)1.86x

Asset Turnover (Annual)1.43x

52-Week High$14.02

Operating Margin (5Y Avg)4.18%

EPS Excl Extra (Annual)$0.31

CapEx CAGR (5Y)-12.48%

Tangible BV CAGR (5Y)11.28%

26-Week Price Return34.13%

Quick Ratio (Annual)1.53x

13-Week Price Return50.22%

Total Debt / Equity (Annual)0.34x

Current Ratio (Quarterly)2.50x

Enterprise Value$286.35M

Revenue / Share Growth (5Y)8.68%

Asset Turnover (TTM)1.45x

Book Value / Share Growth (5Y)7.16%

Revenue / Employee (Annual)$311,100

Inventory Turnover (Annual)10.59x

Pretax Margin (Annual)7.41%

Cash / Share (Annual)$0.16

3-Month Return Std Dev73.42%

Gross Margin (5Y Avg)54.82%

Net Income / Employee (TTM)$18,500

EBITDA CAGR (5Y)0.18%

EBITDA Interim CAGR (5Y)17.21%

ROE (Last FY)11.56%

Net Interest Coverage (Annual)12.10x

EPS Basic Excl Extra (Annual)$0.31

P/FCF (TTM)19.89x

Receivables Turnover (TTM)5.35x

EV / Free Cash Flow (TTM)22.81x

Total Debt / Equity (Quarterly)0.35x

EPS Incl Extra (TTM)$0.41

Receivables Turnover (Annual)6.25x

ROI (TTM)10.98%

P/S Ratio (TTM)1.86x

Pretax Margin (5Y Avg)2.80%

Revenue / Share (Annual)$6.80

Tangible BV / Share (Annual)$2.50

Forward P/E29.13x

Free OCF CAGR (5Y)36.11%

Price vs S&P 500 (52W)28.71%

P/E Ratio (TTM)31.24x

EPS Growth TTM (YoY)72.10%

Year-to-Date Return49.39%

5-Day Price Return-1.47%

EPS Normalized (Annual)$0.31

ROA (5Y Avg)2.24%

Net Profit Margin (Annual)4.62%

Month-to-Date Return3.96%

Cash Flow / Share (TTM)$0.61

EBITD / Share (Annual)$0.67

EPS Growth (3Y)632.25%

Operating Margin (Annual)8.31%

LT Debt / Equity (Annual)0.34x

P/CF (TTM)11.42x

ROI (5Y Avg)2.87%

P/E Excl Extra (TTM)31.24x

LT Debt / Equity (Quarterly)0.35x

EPS Basic Excl Extra (TTM)$0.41

P/TBV (Quarterly)3.70x

P/B Ratio (Annual)3.18x

Inventory Turnover (TTM)10.90x

Pretax Margin (TTM)8.52%

Book Value / Share (Annual)$2.84

Price vs S&P 500 (13W)47.54%

Net Margin Growth (5Y)-23.64%

Beta1.42x

P/FCF (Annual)16.98x

Revenue / Share (TTM)$6.85

ROE (TTM)14.81%

52-Week Low$7.29

vGradeB

gGradeC

mGradeA

vgmGradeB

INFU Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	$0.10	$0.15	+42.86%(+$0.05)
Q1 2026	May 7, 2026	$0.03	$0.05	+47.06%(+$0.02)
Q4 2025	Feb 24, 2026	$0.07	$0.10	+38.89%(+$0.03)
Q3 2025	Nov 4, 2025	$0.05	$0.15	+195.80%(+$0.10)
Q2 2025	Aug 5, 2025	$0.04	$0.15	+286.12%(+$0.11)

INFU Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.20

4.22

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
INFUInfuSystem Holdings, Inc.	B	C	A	1.9x	8.1%	57.5%	9.3%	$13.40
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About InfuSystem Holdings, Inc.

InfuSystems Holdings Inc is a healthcare services provider offering durable medical equipment (DME), consumables, and related support services to patients and healthcare providers. The company operates two segments: Patient Services (primary revenue driver) providing DME supply, order fulfillment, 24/7 clinical support, and insurance billing services; and Device Solutions offering equipment rentals and sales with biomedical support. The integrated platform manages the complete DME care cycle, combining supply, logistics, and clinical support services.

INFU Next Earnings Report

Report dateNov 3, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$0.12

Revenue estimate$37.28M

Also reporting on Nov 3, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments
CVCapsoVision, Inc. Common StockElectromedical Equipment
SMTISanara MedTech Inc. Common StockOrthopedic & Prosthetic Devices
OPTXSyntec Optics Holdings, Inc. Class A Common StockOptical Instruments & Lenses
NAUTNautilus Biotechnolgy, Inc. Common StockLab Analytical Instruments
EYPTEyePoint, Inc. Common StockLab Analytical Instruments
QSIQuantum-Si Incorporated Class A Common StockMeasuring & Controlling Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Strong Buy

Consensus rating

52-Week Range

Low$7.29

High$14.02